Clinical Survey Study to Assess Physical Function and the Incidence of Hypoglycemia in Patients 1 Year of Age and Over With GSD III

Trial Information
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Observational
Summary

The primary objective of this study is to evaluate the incidence of hypoglycemia in adult and pediatric participants with glycogen storage disease type III (GSD III).

Am I eligible for this trial?
Participation Requirements
Sex:
All
Minimum Age:
1
Healthy Volunteers:
No

• Diagnosis of GSD III, confirmed by amylo-alpha-1,6-glucosidase 4-alpha-glucanotransferase (AGL) sequencing or glycogen debranching enzyme (GDE) enzymatic testing

Where is this trial taking place?
United States
Pennsylvania
Children's Hospital of Philadelphia
Recruiting
Philadelphia
Texas
University of Texas
Recruiting
Houston
Who do I contact about this trial?
Primary
Patients Contact: Trial Recruitment
TrialRecruitment@ultragenyx.com
1-888-756-8657
Backup
HCPs Contact: Medical Information
medinfo@ultragenyx.com
1-888-756-8657
When is this trial taking place?
Start Date: May 20, 2022
Estimated Completion Date: February 2023
How many participants will be in this trial?
Target number of participants: 25
What other conditions are being studied in this trial?

This content was sourced from clinicaltrials.gov